-transparent.png){kind=logo}
Two new commercial assays for the detection of degradation products of fibrinogen/fibrin (FDP) were evaluated against two standard procedures. The first, a new hemagglutination inhibition (HAI) assay using glutaraldehyde-treated cells, was compared with the tanned red cell hemagglutination inhibition immunoassay (TRCHII). Analysis of 43 samples from patients with a variety of bleeding disorders and thrombotic conditions showed a high degree of correlation between methods (r = 0.934). The second new assay, a rapid slide test using antibody-coated latex particles, was compared with results obtained by electroimmunoassay. There were no significant differences in the results as assessed by two statistical parameters. It was concluded that both new tests are useful for routine use in clinical laboratories.
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
January 1976,
Nihon rinsho. Japanese journal of clinical medicine,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
January 1983,
Laboratornoe delo,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
January 1974,
Vutreshni bolesti,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
January 1980,
Annals of clinical and laboratory science,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
February 1974,
American journal of clinical pathology,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
February 1972,
Polskie Archiwum Medycyny Wewnetrznej,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
January 1972,
Acta clinica Belgica,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
September 1976,
Scandinavian journal of clinical and laboratory investigation,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
October 1972,
American journal of clinical pathology,
K Sumner, and
E Feller, and
D K Galanakis, and
M W Mosesson
August 1976,
Thrombosis research,
